Replies to post #89443 on Innovation Pharmaceuticals Inc (IPIX)

[cabel]

Great response Leo!!!

Thanks for sharing!

[thefamilyman]

That's strong!

We have excellent and exceptional technology in our compounds. For us to not run multiple programs would be not the right strategy. The potential GI market is likely to be significantly greater for CTIX then anti-biotics and we feel very confident with our product. During these months much research has gone into this. We very much want to enter the GI market. - Leo

[FarmaZutical]

I have to admit that Leo is very thorough and respectful when answering shareholder emails. I respect that a lot.

[JTORENCE]

Agree they have the technology, but not the experience to get over the humps in a timely manner
Time for a partnership with an experienced pharma that can open the doors for CTIX ..imo

[rtwbybike]

Leo is more polite than I would have been. Whoever "Tom" is, he sounds like a rude a-hole.

[Anthropoid]

fill time valleys with value .

[Amatuer17]

Nice response - it shows his long term thinking

When you read the response - specially Prurisol - it shows the number of steps and hurdles that need to be addressed before the trial can start - which adds to the delay.

So working on multiple trials at the same time makes sense. However the lack of resources (people and money) may make these tasks much more difficult for Leo.

The Tom guy seems clearly rude and does not have professional courtsey while communicating.

[Darwinian]

Excellent and dignified reply. Way to disregard the hostility and defend with fact ands and information. FWIW, I liked what I saw here in Leo's reply.

[Fletch]

Not sure a GI drug will be bigger for us then the worlds next antibiotic of choice. Maybe board docs can answer this. Now if both are the same drug......
Fletch

[TheMonolith]

Interesting divide developing over CTIX the past several weeks. Some don't want to question anything, and think full trust should be given. Others are scratching their head over recent events and communications.

[Astavakra]

Thanks, taas. Leo's response should be required reading for everyone who thinks that things should be moving at their own fabricated timeline. Leo lays out the reality and shows the efficiency with which CTIX is moving around the gameboard.
And, yes, Tom comes across as a boor; Leo, a gentleman.

[58nout]

This should be required reading for all of our scholarly posters, transparent traders and prognosticators along with new investors.
On second thought, it should be stickeyed and notated as "real diligence"!

Hi Tom,
I would disagree. There are always time lags in trials especially between phases. Take Prurisol as an example. We completed the crossover study. We need to wait for the lab results. OK, we were successful. Now the data has to be compiled, a briefing book prepared, etc. You then have a successful meeting with the FDA whereby they allow the Phase 2. Okay, you now call your manufacturer and place a order 2to source and manufacture your drug under cGMP conditions. That takes time. Now the FDA has authorized 4 arms with dosing of 2 pills taken twice a day.
So we now need to blister pack per cGMP each arm under instructions and coding from the statistician as it is blinded.
Arm 1 -no active in either AM or PM
Arm 2- 1 active in AM- No active in PM
Arm 3- 1 active AM- 1 active PM
Arm 4- 2 active AM- 2 active PM
Active means Prurisol

This takes time.

After delivery of the drug to sites, there is a lag time as well. Unfortunately no one has figured out a shortcut to this. We must therefore follow the rules meticulously.

We have excellent and exceptional technology in our compounds. For us to not run multiple programs would be not the right strategy. The potential GI market is likely to be significantly greater for CTIX then anti-biotics and we feel very confident with our product. During these months much research has gone into this. We very much want to enter the GI market.

Best wishes,

Leo Ehrlich | CEO |

cellceutix